1. Home
  2. GNLX vs CURR Comparison

GNLX vs CURR Comparison

Compare GNLX & CURR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • CURR
  • Stock Information
  • Founded
  • GNLX 2001
  • CURR 2013
  • Country
  • GNLX United States
  • CURR Singapore
  • Employees
  • GNLX N/A
  • CURR N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • CURR Business Services
  • Sector
  • GNLX Health Care
  • CURR Consumer Discretionary
  • Exchange
  • GNLX Nasdaq
  • CURR Nasdaq
  • Market Cap
  • GNLX 103.6M
  • CURR 89.8M
  • IPO Year
  • GNLX 2023
  • CURR N/A
  • Fundamental
  • Price
  • GNLX $2.27
  • CURR $1.96
  • Analyst Decision
  • GNLX Strong Buy
  • CURR
  • Analyst Count
  • GNLX 4
  • CURR 0
  • Target Price
  • GNLX $18.25
  • CURR N/A
  • AVG Volume (30 Days)
  • GNLX 142.7K
  • CURR 1.2M
  • Earning Date
  • GNLX 11-14-2024
  • CURR 02-11-2025
  • Dividend Yield
  • GNLX N/A
  • CURR N/A
  • EPS Growth
  • GNLX N/A
  • CURR N/A
  • EPS
  • GNLX N/A
  • CURR N/A
  • Revenue
  • GNLX $8,000.00
  • CURR $48,723,898.00
  • Revenue This Year
  • GNLX N/A
  • CURR N/A
  • Revenue Next Year
  • GNLX N/A
  • CURR N/A
  • P/E Ratio
  • GNLX N/A
  • CURR N/A
  • Revenue Growth
  • GNLX N/A
  • CURR N/A
  • 52 Week Low
  • GNLX $1.60
  • CURR $1.19
  • 52 Week High
  • GNLX $16.60
  • CURR $5.74
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 38.68
  • CURR N/A
  • Support Level
  • GNLX $2.13
  • CURR N/A
  • Resistance Level
  • GNLX $2.80
  • CURR N/A
  • Average True Range (ATR)
  • GNLX 0.20
  • CURR 0.00
  • MACD
  • GNLX -0.04
  • CURR 0.00
  • Stochastic Oscillator
  • GNLX 14.21
  • CURR 0.00

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

About CURR Currenc Group Inc. Ordinary Shares

Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants worldwide, delivering frictionless interoperable real-time fund transfers and instant messaging.

Share on Social Networks: